PharmaLogic Launches Advanced Radiopharmaceutical Facility in Cincinnati

• PharmaLogic, a CDMO and radiopharmacy solutions provider, has opened a new radiopharmaceutical production and research facility in Cincinnati, OH.

PharmaLogic has announced the opening of its new radiopharmaceutical production and research facility in Cincinnati, Ohio. The facility was officially opened on April 22, 2024.

The new production and laboratory space is equipped to allow PharmaLogic to increase current production levels and concentrate additional efforts on the research and development of novel compounds.

Steve Chilinski, CEO of PharmaLogic said “With this new cyclotron facility, we’re excited to be partnering with healthcare providers in the region to bring advanced radiopharmaceuticals to the patient community that will be the foundation for game-changing diagnosis and treatment of cancers, and neurological and heart diseases.”

D. Scott Holbrook, Chief Strategy Officer and General Manager of PharmaLogic, highlighted the broader implications of the new facility. “The impact of this facility extends far beyond expanding access to innovative radiopharmaceuticals for the greater Cincinnati community. The cutting-edge laboratory will empower PharmaLogic to advance a robust pipeline of novel radiopharmaceutical candidates, ultimately benefiting patients nationwide.”